Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction

Objective. The PleurX® IPC system has been used extensively in the past. Over time, management of MPE with the PleurX system can be costly. The new ASEPT pleural catheter, through advantages in design, may ultimately show cost savings. The primary outcome of this study was to evaluate safety and eff...

Full description

Bibliographic Details
Main Authors: Inderdeep Dhaliwal, Masoud Mahdavian, Shabnam Asghari, Benson Chun To Wong, Rosalie Labelle, Kayvan Amjadi
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2016/4273480
id doaj-a3f7d0eb536f473789d9d27ad53b5b41
record_format Article
spelling doaj-a3f7d0eb536f473789d9d27ad53b5b412021-07-02T03:24:54ZengHindawi LimitedCanadian Respiratory Journal1198-22411916-72452016-01-01201610.1155/2016/42734804273480Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient SatisfactionInderdeep Dhaliwal0Masoud Mahdavian1Shabnam Asghari2Benson Chun To Wong3Rosalie Labelle4Kayvan Amjadi5Schulich School of Medicine, Western University, Victoria Hospital, London Health Sciences Centre, London, ON, CanadaDivision of Respirology, Faculty of Medicine, Memorial University of Newfoundland (MUN), St. John’s, NL, CanadaDiscipline of Family Medicine, Health Sciences Centre, Memorial University of Newfoundland (MUN), St. John’s, NL, CanadaDivision of Respirology, University of Ottawa, The Ottawa Hospital, Ottawa, ON, CanadaDepartment of Medicine, Division of Interventional Pulmonology, The Ottawa Hospital, Ottawa, ON, CanadaDivision of Interventional Pulmonology, University of Ottawa, The Ottawa Hospital, Ottawa, ON, CanadaObjective. The PleurX® IPC system has been used extensively in the past. Over time, management of MPE with the PleurX system can be costly. The new ASEPT pleural catheter, through advantages in design, may ultimately show cost savings. The primary outcome of this study was to evaluate safety and efficacy of the ASEPT system. Method. This single centre, prospective study enrolled 50 patients with MPE, who were followed for as long as they were alive with a catheter. Quality of Life (QoL) was assessed before, at 2 weeks, and 6 weeks after ASEPT catheter insertion using the EORTC QLQ-C30 and LC13 questionnaires. Ease of catheter use and complications were reported by physician and community nurses. Results. 50 patients with MPE with a mean age of 64.5±1.9, BDI of 2.8±0.9, and ECOG score of 3.0±0.7 were recruited. No immediate or long-term complications were reported during the study period. Compared to precatheter insertion, global health status (−18, p<0.001), QLQ-C30 dyspnea (−39, p<0.00001), and LC13 dyspnea (−11, p<0.0005) significantly improved at 2 and 6 weeks after intervention. Provider surveys indicated favourable ease of use. Conclusion. The new ASEPT catheter offers a safe and effective option for the management of MPE.http://dx.doi.org/10.1155/2016/4273480
collection DOAJ
language English
format Article
sources DOAJ
author Inderdeep Dhaliwal
Masoud Mahdavian
Shabnam Asghari
Benson Chun To Wong
Rosalie Labelle
Kayvan Amjadi
spellingShingle Inderdeep Dhaliwal
Masoud Mahdavian
Shabnam Asghari
Benson Chun To Wong
Rosalie Labelle
Kayvan Amjadi
Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
Canadian Respiratory Journal
author_facet Inderdeep Dhaliwal
Masoud Mahdavian
Shabnam Asghari
Benson Chun To Wong
Rosalie Labelle
Kayvan Amjadi
author_sort Inderdeep Dhaliwal
title Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title_short Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title_full Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title_fullStr Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title_full_unstemmed Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title_sort management of malignant pleural effusion with asept® pleural catheter: quality of life, feasibility, and patient satisfaction
publisher Hindawi Limited
series Canadian Respiratory Journal
issn 1198-2241
1916-7245
publishDate 2016-01-01
description Objective. The PleurX® IPC system has been used extensively in the past. Over time, management of MPE with the PleurX system can be costly. The new ASEPT pleural catheter, through advantages in design, may ultimately show cost savings. The primary outcome of this study was to evaluate safety and efficacy of the ASEPT system. Method. This single centre, prospective study enrolled 50 patients with MPE, who were followed for as long as they were alive with a catheter. Quality of Life (QoL) was assessed before, at 2 weeks, and 6 weeks after ASEPT catheter insertion using the EORTC QLQ-C30 and LC13 questionnaires. Ease of catheter use and complications were reported by physician and community nurses. Results. 50 patients with MPE with a mean age of 64.5±1.9, BDI of 2.8±0.9, and ECOG score of 3.0±0.7 were recruited. No immediate or long-term complications were reported during the study period. Compared to precatheter insertion, global health status (−18, p<0.001), QLQ-C30 dyspnea (−39, p<0.00001), and LC13 dyspnea (−11, p<0.0005) significantly improved at 2 and 6 weeks after intervention. Provider surveys indicated favourable ease of use. Conclusion. The new ASEPT catheter offers a safe and effective option for the management of MPE.
url http://dx.doi.org/10.1155/2016/4273480
work_keys_str_mv AT inderdeepdhaliwal managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
AT masoudmahdavian managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
AT shabnamasghari managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
AT bensonchuntowong managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
AT rosalielabelle managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
AT kayvanamjadi managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
_version_ 1721341640224800768